Suppr超能文献

心脏移植后孤立性与合并性2型肺动脉高压的30年趋势及预后

Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation.

作者信息

Nasri Amine, Dupuis Jocelyn, Carrier Michel, Racine Normand, Parent Marie-Claude, Ducharme Anique, Fortier Annik, Hausermann Leslie, White Michel, Tremblay-Gravel Maxime

机构信息

Montreal Heart Institute Research Center, Montreal, QC, Canada.

Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.

出版信息

Front Cardiovasc Med. 2022 Dec 2;9:841025. doi: 10.3389/fcvm.2022.841025. eCollection 2022.

Abstract

AIM

To investigate the effect of the new definition of pulmonary hypertension (PH) and new pulmonary vascular resistance (PVR) thresholds on the prevalence, clinical characteristics, and events following cardiac transplantation (CTx) over 30 years.

METHODS

Patients who underwent CTx between 1983 and 2014 for whom invasive hemodynamic data was available were analyzed ( = 342). Patients transplanted between 1983 and 1998 were classified as early era and those transplanted between 1999 and 2014 were classified as recent era. Group 2 PH was diagnosed in the presence of a mean pulmonary artery pressure (mPAP) > 20 mmHg and pulmonary capillary wedge pressure (PCWP) > 15 mmHg. Isolated post capillary PH (Ipc-PH) was defined as PVR ≤ 2 wood units and combined pre and post capillary PH (Cpc-PH) was defined PVR > 2 wood units. Moderate to severe PH was defined as mPAP ≥ 35 mmHg. The primary outcome was 30-day mortality and long-term mortality according to type and severity of PH. Proportions were analyzed using the chi-square test, and survival analyses were performed using Kaplan-Meier curves and compared using the logrank test.

RESULTS

The prevalence of PH in patients transplanted in the early era was 89.1%, whilst 84.2% of patients transplanted in the recent era had PH ( = 0.3914). There was no difference in the prevalence of a pre-capillary component according to era ( = 0.4001), but severe PH was more common in the early era (51.1% [early] vs 38.0% [recent] = 0.0151). Thirty-day and long-term  mortality  were  not  significantly  associated  with severity or type of PH. There was a trend toward increased 30-day mortality in mild PH (10.1%), compared to no PH (4.4%) and moderate to severe PH (6.6%; = 0.0653). Long-term mortality did not differ according to the severity of PH ( = 0.1480). There were no significant differences in 30-day or long-term mortality in IpcPH compared to CpcPH ( = 0.3974 vs = 0.5767, respectively).

CONCLUSION

Over 30 years, PH has remained very prevalent before CTx. The presence, severity, and type (pre- vs post-capillary) of PH is not significantly associated with short- or long-term mortality.

摘要

目的

探讨肺动脉高压(PH)的新定义及新的肺血管阻力(PVR)阈值对30年间心脏移植(CTx)的患病率、临床特征及相关事件的影响。

方法

对1983年至2014年间接受CTx且有创血流动力学数据的患者进行分析(n = 342)。将1983年至1998年间接受移植的患者归为早期,1999年至2014年间接受移植的患者归为近期。当平均肺动脉压(mPAP)>20 mmHg且肺毛细血管楔压(PCWP)>15 mmHg时诊断为2组PH。孤立性毛细血管后PH(Ipc-PH)定义为PVR≤2伍德单位,合并毛细血管前和毛细血管后PH(Cpc-PH)定义为PVR>2伍德单位。中度至重度PH定义为mPAP≥35 mmHg。主要结局是根据PH的类型和严重程度的30天死亡率和长期死亡率。采用卡方检验分析比例,使用Kaplan-Meier曲线进行生存分析并使用对数秩检验进行比较。

结果

早期接受移植患者的PH患病率为89.1%,而近期接受移植患者的PH患病率为84.2%(P = 0.3914)。根据时期,毛细血管前成分的患病率无差异(P = 0.4001),但重度PH在早期更常见(51.1%[早期]对38.0%[近期],P = 0.0151)。30天和长期死亡率与PH的严重程度或类型无显著相关性。与无PH(4.4%)和中度至重度PH(6.6%)相比,轻度PH的30天死亡率有增加趋势(10.1%;P = 0.0653)。长期死亡率根据PH的严重程度无差异(P = 0.1480)。IpcPH与CpcPH相比,30天或长期死亡率无显著差异(分别为P = 0.3974对P = 0.5767)。

结论

30多年来,PH在CTx前一直非常普遍。PH的存在、严重程度和类型(毛细血管前与毛细血管后)与短期或长期死亡率无显著相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce37/9755656/c9b6e0fa36fb/fcvm-09-841025-g001.jpg

相似文献

1
Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation.
Front Cardiovasc Med. 2022 Dec 2;9:841025. doi: 10.3389/fcvm.2022.841025. eCollection 2022.
2
Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation.
Am J Cardiol. 2020 Sep 15;131:60-66. doi: 10.1016/j.amjcard.2020.06.037. Epub 2020 Jun 30.
7
Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
PLoS One. 2021 Mar 2;16(3):e0247987. doi: 10.1371/journal.pone.0247987. eCollection 2021.
9
Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.
Transplant Proc. 2023 Dec;55(10):2462-2469. doi: 10.1016/j.transproceed.2023.09.022. Epub 2023 Nov 18.

引用本文的文献

本文引用的文献

1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
2
Impact of Preoperative Pulmonary Hypertension on Survival in Patients Undergoing Elective Heart Transplant.
Transplant Proc. 2020 Mar;52(2):580-583. doi: 10.1016/j.transproceed.2019.11.034. Epub 2020 Feb 10.
3
4
Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile.
Chest. 2020 Jan;157(1):151-161. doi: 10.1016/j.chest.2019.07.028. Epub 2019 Aug 22.
5
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
7
Honoring 50 Years of Clinical Heart Transplantation in : In-Depth State-of-the-Art Review.
Circulation. 2018 Jan 2;137(1):71-87. doi: 10.1161/CIRCULATIONAHA.117.029753.
8
Heart Transplantation in Patients >60 Years: Importance of Relative Pulmonary Hypertension and Right Ventricular Failure on Midterm Survival.
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):32-40. doi: 10.1053/j.jvca.2017.09.017. Epub 2017 Sep 18.
9
Re-examining Factors Associated With Mortality After Heart Transplantation: A Focus on Recipient Age and Relative Pulmonary Hypertension.
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):41-43. doi: 10.1053/j.jvca.2017.11.004. Epub 2017 Nov 4.
10
The Development of Pulmonary Hypertension Results in Decreased Post-Transplant Survival.
ASAIO J. 2018 Jul/Aug;64(4):508-514. doi: 10.1097/MAT.0000000000000682.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验